The actual device was returned to the manufacturing facility for evaluation.Visual inspection of the actual sample upon receipt found no obvious abnormalities which could have caused or contributed to the reported insufficient gas transfer performance.The actual device was sterilized with glutaraldehyde solution and the housing component was removed for further inspection of the inside of the oxygenator module.Visual inspection did not find any thrombus formation either on the filter or the inside of the fiber layer.After removing the fiber layer, the heat exchanger module was inspected under magnification.There was no formation of thrombus on the outer cylinder of the heat exchanger module.The fiber that had been removed from the oxygenator module was inspected under magnification, and it was confirmed there was no presence of thrombus.A review of the device history record of the involved product/lot# combination confirmed there were no indications of production related anomalies.A search of the complaint file found no other report with the involved product/lot# combination.The provided perfusion record was reviewed.The patient was (b)(6).Pao2 was always kept above 300mmhg all the way through the case.Although an exact cause for the reported issue cannot be determined based on the available information and device evaluation, there is no evidence that this event was related to a device defect or malfunction.The actual sample did not reveal any anomalies that would have contributed to the reported issue.In addition, the perfusion record showed no indications of a decrease in the pao2.The device labeling does address the potential for such an occurrence in the instruction for use (ifu) with the statement such as the following: measure blood gases and make necessary adjustments.Control pao2 by changing concentration of oxygen in ventilating gas using gas blender.To decrease pao2, decrease fio2 and to increase pao2, increase fio2.All available information has been placed on file in quality management for appropriate tracking, trending and follow up.(b)(4).
|